UBS Reduced Holdings in Alkermes

Summary

UBS Asset Management’s Oconnor division reduced its holdings in Alkermes plc (NASDAQ: ALKS) by 80.6% in the fourth quarter, now holding 9,710 shares valued at $279,000. Other investors adjusted their positions as well, with significant increases from Eversource Wealth Advisors and Smartleaf Asset Management. Analysts have mixed ratings on Alkermes, with a general consensus of ‘moderate buy’ and a target price of $38.33. Alkermes reported Q1 EPS of $0.13, missing expectations, with revenue down 12.6% year-over-year. Market Beat

Impact Analysis

The reduction in UBS’s holdings of Alkermes suggests a bearish sentiment or reallocation strategy, likely influenced by Alkermes’ underperformance in the recent quarter, as indicated by missing EPS expectations and declining revenue. This could signal concerns about the company’s ability to generate growth in the near term. On the other hand, increased holdings by Eversource Wealth Advisors and Smartleaf Asset Management could indicate differing assessments or longer-term optimism about recovery potential.Market Beat Analyst ratings are mixed, showing uncertainty in the market about Alkermes’ ability to meet growth targets. UBS’s reduction in holdings may also be part of a broader strategic shift, as evidenced by its adjustments in other investments, such as increasing its stake in Meilan Airport.Zhitong+ 2 Overall, this event reflects a cautious outlook on Alkermes, with potential risks related to its financial performance and market position. Investors should consider these factors when evaluating Alkermes’ stock potential.